Prednisone Tablet
FDA Label NDC 55154-2147

53 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Prednisone (NDC 55154-2147). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 8416621/0623, description, clinical pharmacology, indications and usage, contraindications, general, cardio-renal, endocrine, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-2146-0

PredniSONE TABLETS, USP

5 mg

10 TABLETS

5mg Bag Label (46a0c9d3 8ce8 D59e E063 6294a90ab258 01)

5mg Bag Label (46a0c9d3 8ce8 D59e E063 6294a90ab258 01)

NDC 55154-2147-0

PredniSONE

Tablets, USP

20 mg

10 TABLETS

20mg Bag Label (46a0c9d3 8ce8 D59e E063 6294a90ab258 00)

20mg Bag Label (46a0c9d3 8ce8 D59e E063 6294a90ab258 00)

* Please review the disclaimer below.